iBio, Inc. IBIO
NASDAQ IBIO
$0.82 +0.04 (+5.67%)
At close: Nov 11, 2026 · 4:00 PM EST

iBio (IBIO) Gross Margin (2009 - 2022)

Updated

iBio (IBIO) reported Gross Margin of 115.02% for FY2022 (year ended Jun 30, 2022), up 76.68 percentage points from 38.34% in FY2021.

Analysis

iBio (IBIO) Gross Margin (2009 - 2022) Analysis & Trends

  • According to Business Quant data, Gross Margin came in at 38.34% in FY2021 (-18.74 pp) and 57.08% in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 83.88%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 68.12%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 75.38%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 72.95%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 88.03%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 73.10%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 81.07%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 75.71%
10 iBio 118.23 Mn -174.02 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 105.28%
Sep 30, 2021 203.57%
Jun 30, 2021 61.91%
Mar 31, 2021 35.56%
Dec 31, 2020 70.07%
Sep 30, 2020 73.90%
Jun 30, 2020 73.30%
Mar 31, 2020 10.42%
Jun 30, 2009 97.28%
Mar 31, 2009 49.10%
API Access

iBio Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=IBIO&period=max&api_key=YOUR_API_KEY